NeuroPace (NPCE) Property, Plant & Equipment (Net) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.38 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.89 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.18 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 4.06 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.82 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.56 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.10 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.16 Bn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 998,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 949,000.00 |
| Sep 30, 2023 | 949,000.00 |
| Jun 30, 2023 | 976,000.00 |
| Jun 30, 2023 | 976,000.00 |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 894,000.00 |
| Sep 30, 2022 | 894,000.00 |
| Jun 30, 2022 | 951,000.00 |
| Jun 30, 2022 | 951,000.00 |
| Mar 31, 2022 | 860,000.00 |
| Mar 31, 2022 | 860,000.00 |
| Dec 31, 2021 | 603,000.00 |
| Dec 31, 2021 | 603,000.00 |
| Sep 30, 2021 | 624,000.00 |
| Sep 30, 2021 | 624,000.00 |
| Jun 30, 2021 | 425,000.00 |
| Jun 30, 2021 | 425,000.00 |
| Mar 31, 2021 | 476,000.00 |
| Mar 31, 2021 | 476,000.00 |
| Dec 31, 2020 | 515,000.00 |
| Dec 31, 2020 | 515,000.00 |